344 related articles for article (PubMed ID: 19628385)
21. Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231.
Gallagher SM; Castorino JJ; Wang D; Philp NJ
Cancer Res; 2007 May; 67(9):4182-9. PubMed ID: 17483329
[TBL] [Abstract][Full Text] [Related]
22. MCT1 and its accessory protein CD147 are differentially regulated by TSH in rat thyroid cells.
Fanelli A; Grollman EF; Wang D; Philp NJ
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1223-9. PubMed ID: 14607782
[TBL] [Abstract][Full Text] [Related]
23. Sequence variations and two levels of MCT1 and CD147 expression in red blood cells and gluteus muscle of horses.
Koho NM; Mykkänen AK; Reeben M; Raekallio MR; Ilves M; Pösö AR
Gene; 2012 Jan; 491(1):65-70. PubMed ID: 21945690
[TBL] [Abstract][Full Text] [Related]
24. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
[TBL] [Abstract][Full Text] [Related]
25. Sex Hormones Regulate Rat Hepatic Monocarboxylate Transporter Expression and Membrane Trafficking.
Cao J; Ng M; Felmlee MA
J Pharm Pharm Sci; 2017; 20(1):435-444. PubMed ID: 29249221
[TBL] [Abstract][Full Text] [Related]
26. Polarized lactate transporter activity and expression in the syncytiotrophoblast of the term human placenta.
Settle P; Mynett K; Speake P; Champion E; Doughty IM; Sibley CP; D'Souza SW; Glazier J
Placenta; 2004 Jul; 25(6):496-504. PubMed ID: 15135232
[TBL] [Abstract][Full Text] [Related]
27. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
[TBL] [Abstract][Full Text] [Related]
28. Expression, cellular localization, and functional role of monocarboxylate transporter 4 (MCT4) in the gastrointestinal tract of ruminants.
Kirat D; Matsuda Y; Yamashiki N; Hayashi H; Kato S
Gene; 2007 Apr; 391(1-2):140-9. PubMed ID: 17289302
[TBL] [Abstract][Full Text] [Related]
29. Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression.
Chen H; Wang L; Beretov J; Hao J; Xiao W; Li Y
Clin Exp Metastasis; 2010 Dec; 27(8):557-69. PubMed ID: 20658178
[TBL] [Abstract][Full Text] [Related]
30. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
31. MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma.
Fisel P; Stühler V; Bedke J; Winter S; Rausch S; Hennenlotter J; Nies AT; Stenzl A; Scharpf M; Fend F; Kruck S; Schwab M; Schaeffeler E
Oncotarget; 2015 Oct; 6(31):30615-27. PubMed ID: 26384346
[TBL] [Abstract][Full Text] [Related]
32. Monocarboxylate transporters (MCT) as lactate carriers in equine muscle and red blood cells.
Koho NM; Hyyppä S; Pösö AR
Equine Vet J Suppl; 2006 Aug; (36):354-8. PubMed ID: 17402447
[TBL] [Abstract][Full Text] [Related]
33. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
[TBL] [Abstract][Full Text] [Related]
34. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
[TBL] [Abstract][Full Text] [Related]
35. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection.
Li Y; Xu J; Chen L; Zhong WD; Zhang Z; Mi L; Zhang Y; Liao CG; Bian HJ; Jiang JL; Yang XM; Li XY; Fan CM; Zhu P; Fu L; Chen ZN
Histopathology; 2009 May; 54(6):677-87. PubMed ID: 19438743
[TBL] [Abstract][Full Text] [Related]
36. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
[TBL] [Abstract][Full Text] [Related]
37. The monocarboxylate transporter family--role and regulation.
Halestrap AP; Wilson MC
IUBMB Life; 2012 Feb; 64(2):109-19. PubMed ID: 22162139
[TBL] [Abstract][Full Text] [Related]
38. Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression.
Hao J; Chen H; Madigan MC; Cozzi PJ; Beretov J; Xiao W; Delprado WJ; Russell PJ; Li Y
Br J Cancer; 2010 Sep; 103(7):1008-18. PubMed ID: 20736947
[TBL] [Abstract][Full Text] [Related]
39. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44.
Pinheiro C; Reis RM; Ricardo S; Longatto-Filho A; Schmitt F; Baltazar F
J Biomed Biotechnol; 2010; 2010():427694. PubMed ID: 20454640
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
